MedPath

杭州中美华东制药有限公司

Ownership
-
Established
1992-12-31
Employees
-
Market Cap
-
Website
www.eastchinapharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

98

NMPA:98

Drug Approvals

Mycophenolate Mofetil for Suspension

Product Name
吗替麦考酚酯干混悬剂
Approval Number
国药准字H20253453
Approval Date
Feb 25, 2025
NMPA

Ustekinumab Injection

Product Name
赛乐信
Approval Number
国药准字S20240050
Approval Date
Oct 29, 2024
NMPA

Ciclosporin Oral Solution

Product Name
新赛斯平
Approval Number
国药准字H10930130
Approval Date
Sep 20, 2024
NMPA

Mycophenolate Mofetil Dispersible Tablets

Product Name
赛可平
Approval Number
国药准字H20052083
Approval Date
Sep 14, 2024
NMPA

Pioglitazone Hydrochloride Tablets

Product Name
卡司平
Approval Number
国药准字H20060664
Approval Date
Sep 14, 2024
NMPA

Pantoprazole Sodium for Injection

Product Name
泮立苏
Approval Number
国药准字H20050668
Approval Date
Sep 14, 2024
NMPA

百令胶囊

Approval Number
国药准字Z10910036
Approval Date
Sep 4, 2024
NMPA

Clarithromycin Tablets

Product Name
卡斯迈欣
Approval Number
国药准字H10970216
Approval Date
Aug 27, 2024
NMPA

Pantoprazole Sodium for Injection

Product Name
泮立苏
Approval Number
国药准字H20204013
Approval Date
Aug 24, 2024
NMPA

Sirolimus Oral Solution

Product Name
赛莫司
Approval Number
国药准字H20051081
Approval Date
Aug 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.